Outcomes4Me, a breast cancer information and treatment navigation app, raised $12 million in a Series A round.
Northpond Ventures led the funding round with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal, IRA Capital, and others. As part of the investment, Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me’s board.
According to Outcomes4Me, the new funds will be used to extend the company’s platform beyond breast cancer to other cancers, grow the platform’s regulatory-grade dataset, and expand to more patients in Europe.
Outcomes4Me helps patients navigate their cancer treatment journey using a personalized app that provides relevant evidence-based information. The app uses AI and natural language processing techniques to personalize information for each patient, factoring in their clinical histories, personal preferences, and broader context, the company said. The app also empowers patients to stay informed, understand their treatment options, find clinical trials, manage their quality of life, and ultimately advocate for themselves.
“We are thrilled to partner with Northpond Ventures. Their science-driven approach and global reach make them a strategic partner in our quest to democratize cancer care and accelerate research, empowering patients around the world to achieve better outcomes,” said Maya R. Said, Sc. D., Founder and CEO of Outcomes4Me. “This latest round of financing will be used to magnify our reach to meet patients where they are and support them in their fights against all types of cancers.”
“Despite tremendous acceleration in new cancer drug approvals, there is much to learn to further understand disease progression. Real-world longitudinal data, including both clinical and patient-reported, is critical to better understand and improve cancer care,” said Jackson. “Outcomes4Me has an enormous opportunity to improve access to drug trials and cultivate a patient-first treatment approach. We look forward to working with the team to transform the lives of millions.”
Mobile health apps raised $912 million in Q1 2021, a 116% increase compared to $421 million in Q4 2020, according to the recently released Mercom’s Q1 2021 Digital Health Funding and M&A Report.